These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31207203)

  • 1. Should we still use azithromycin for gonorrhoea treatment?
    Mensforth S; Ross JDC
    Sex Health; 2019 Sep; 16(5):442-448. PubMed ID: 31207203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae?
    Rice LB
    Sex Transm Infect; 2015 Jun; 91(4):238-40. PubMed ID: 25926405
    [No Abstract]   [Full Text] [Related]  

  • 3. First line dual therapy for gonorrhoea to limit the spread of antimicrobial resistance.
    Mohammed H; Sile B; Furegato M; Woodhall S; Fifer H; Hughes G
    BMJ; 2017 Feb; 356():j565. PubMed ID: 28153820
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of azithromycin 1 g single dose in the management of uncomplicated gonorrhoea.
    Waters LJ; Boag FC; Betournay R
    Int J STD AIDS; 2005 Jan; 16(1):84. PubMed ID: 15705283
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between In vitro susceptibility and treatment outcome with azithromycin in gonorrhoea: a prospective study.
    Khaki P; Bhalla P; Sharma A; Kumar V
    Indian J Med Microbiol; 2007 Oct; 25(4):354-7. PubMed ID: 18087084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
    Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
    Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant
    Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H
    Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada.
    Martin I; Sawatzky P; Liu G; Allen V; Lefebvre B; Hoang L; Drews S; Horsman G; Wylie J; Haldane D; Garceau R; Ratnam S; Wong T; Archibald C; Mulvey MR
    Emerg Infect Dis; 2016 Jan; 22(1):65-7. PubMed ID: 26689114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin.
    Whiley DM; Jennison A; Pearson J; Lahra MM
    Lancet Infect Dis; 2018 Jul; 18(7):717-718. PubMed ID: 29976521
    [No Abstract]   [Full Text] [Related]  

  • 10. An era of untreatable gonorrhoea?
    Sutton B; Ivan M
    Med J Aust; 2018 Aug; 209(4):188. PubMed ID: 30107775
    [No Abstract]   [Full Text] [Related]  

  • 11. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.
    Ison CA; Hussey J; Sankar KN; Evans J; Alexander S
    Euro Surveill; 2011 Apr; 16(14):. PubMed ID: 21492528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
    Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M
    APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.
    Unemo M
    BMC Infect Dis; 2015 Aug; 15():364. PubMed ID: 26293005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands.
    Xiridou M; Lugnér A; de Vries HJ; van Bergen JE; Götz HM; van Benthem BH; Wallinga J; van der Sande MA
    Sex Transm Dis; 2016 Sep; 43(9):542-8. PubMed ID: 27513379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Background review for the '2020 European guideline for the diagnosis and treatment of gonorrhoea in adults'.
    Unemo M; Ross J; Serwin AB; Gomberg M; Cusini M; Jensen JS
    Int J STD AIDS; 2021 Feb; 32(2):108-126. PubMed ID: 33323071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial.
    Chen MY; McNulty A; Avery A; Whiley D; Tabrizi SN; Hardy D; Das AF; Nenninger A; Fairley CK; Hocking JS; Bradshaw CS; Donovan B; Howden BP; Oldach D;
    Lancet Infect Dis; 2019 Aug; 19(8):833-842. PubMed ID: 31196813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea.
    Unemo M; Golparian D; Eyre DW
    Methods Mol Biol; 2019; 1997():37-58. PubMed ID: 31119616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level azithromycin-resistant Neisseria gonorrhoeae clinical isolate in France, March 2014.
    Bercot B; Belkacem A; Goubard A; Mougari F; Sednaoui P; La Ruche G; Cambau E
    Euro Surveill; 2014 Nov; 19(44):. PubMed ID: 25394255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
    BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2018-19 International Union against Sexually Transmitted Infections European Collaborative Clinical Group report on the diagnosis and treatment of gonorrhoea in Europe.
    Clarke E; Patel C; Patel R; Unemo M;
    Int J STD AIDS; 2020 Jan; 31(1):77-81. PubMed ID: 31793388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.